Western blot
0.2-1 ug/mlELISA Titer: 1:12500Positive Control: Human heart| Product Name | Rabbit anti-SLC22A8 polyclonal antibody - middle region |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | MGC24086, OAT3 |
| Immunogen | The immunogen for anti-SLC22A8 antibody: synthetic peptide directed towards the middle region of human SLC22A8 |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | DogHuman |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
| Gene Symbol | SLC22A8 |
|---|---|
| Gene Synonyms | MGC24086 OAT3 |
| Gene Full Name | Solute carrier family 22 (organic anion transporter), member 8 |
| Gene Summary | SLC22A8 is involved in the sodium-independent transport and excretion of organic anions, some of which are potentially toxic. SLC22A8 is an integral membrane protein and appears to be localized to the basolateral membrane of the kidney.The protein encoded by this gene is involved in the sodium-independent transport and excretion of organic anions, some of which are potentially toxic. The encoded protein is an integral membrane protein and appears to be localized to the basolateral membrane of the kidney. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications. |
| Alternative Names | MGC24086 OAT3 |
| Molecular Weight(MW) | 60kDa |
| Sequence | 542 amino acids |
Western blot
0.2-1 ug/mlELISA Titer: 1:12500Positive Control: Human heart| Application Notes | WB:1:500~1:2000 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
